Skip to main content

SIG BROKERAGE, LP

Broker-Dealer

Position in CRSP — CRISPR Therapeutics AG

CIK 1094429 BALA CYNWYD, PA

Position in CRSP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$205,787
-$221,246 QoQ
Shares Held
4,326
-34.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Sep 30, 2025
CallValue
$304,607
CallShares
4,700
PutValue
$324,050
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SIG BROKERAGE, LP holds $10,788,089 across 9 Biotechnology names. CRSP ranks #5 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CRSP
CRISPR Therapeutics AG
This page
4,326 $205,787

All Filings in CRSP

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $205,787 4,326
2025-09-30 $304,607 4,700
2025-09-30 $427,033 6,589
2025-09-30 $324,050 5,000
2025-06-30 $228,608 4,700